Skip to main content
. 2020 Dec 9;27(10):1674–1683. doi: 10.1093/ibd/izaa318

FIGURE 3.

FIGURE 3.

Figure provides the chemical structures of JAK inhibitors currently under investigation for Crohn’s disease and/or ulcerative colitis.